Refreshing results…
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Download from doi.orgLow rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
Download from doi.orgSummary of COVID‐19 clinical practice adjustments across select institutions
Download from api.wiley.comMissing publications? Search for publications with a matching author name.